Compounds > naltrexone

naltrexone and Cancer of Liver

naltrexone has been researched along with Cancer of Liver in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chia, BK; Tey, HL1
Harlos, MS; Hohl, CM; Wong, JK1
Berkson, AJ; Berkson, BM; Rubin, DM2

Other Studies

4 other study(ies) available for naltrexone and Cancer of Liver

ArticleYear
Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:12

    Topics: Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neoplasm Metastasis; Paraneoplastic Syndromes; Pruritus; Treatment Outcome

2014
Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.
    Journal of palliative care, 2015, Volume: 31, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Fatal Outcome; Female; Gallbladder Neoplasms; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Quaternary Ammonium Compounds; Terminal Care

2015
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
    Integrative cancer therapies, 2009, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Naltrexone; Pancreatic Neoplasms; Thioctic Acid

2009
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
    Integrative cancer therapies, 2006, Volume: 5, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Naltrexone; Neoplasm Staging; Palliative Care; Pancreatic Neoplasms; Thioctic Acid; Time Factors; Treatment Outcome

2006